BackgroundCheck.run
Search For

Laura L Eggink, 622538 87Th St, Scottsdale, AZ 85257

Known as:
Lavonne Eggink Josh Hubbard
Related to:
Eggink Linda John C Eggink 65

Laura Eggink Phones & Addresses

2538 87Th St, Scottsdale, AZ 85257    480-6993496   

2538 87Th Way, Scottsdale, AZ 85257    480-6993496   

8356 E Via De Encanto, Scottsdale, AZ 85258    602-9981610    480-4836027    480-9981610   

8356 E Vista Dr, Scottsdale, AZ 85250   

9750 N 96Th St #772, Scottsdale, AZ 85258   

Salt Lake City, UT   

Ferndale, WA   

Maricopa, AZ   

Virginia Beach, VA   

Mc Clellandtown, PA   

Social networks

Laura L Eggink

Linkedin

Work

Company: Asus 2005 to 2009 Position: Assistant research professor

Education

School / High School: Arizona State University

Skills

Cell Based Assays • Immunology • Cell Biology • Biotechnology • Drug Discovery • Therapeutics • Cell Culture • Elisa • Sds Page • In Vitro

Industries

Biotechnology
Get Report
Control this profile

Mentions for Laura L Eggink

Laura Eggink resumes & CV records

Resumes

Laura Eggink Photo 13

Founder And Scientist

Location:
Phoenix, AZ
Industry:
Biotechnology
Work:
Asus 2005 - 2009
Assistant Research Professor Susavion Biosciences 2005 - 2009
Founder and Scientist
Education:
Arizona State University
Skills:
Cell Based Assays, Immunology, Cell Biology, Biotechnology, Drug Discovery, Therapeutics, Cell Culture, Elisa, Sds Page, In Vitro

Publications & IP owners

Us Patents

Therapeutic And Diagnostic Peptides

US Patent:
7811995, Oct 12, 2010
Filed:
Dec 12, 2007
Appl. No.:
11/955226
Inventors:
Laura L. Eggink - Scottsdale AZ, US
Kenneth J. Hoober - Phoenix AZ, US
Assignee:
Susavion Biosciences, Inc. - Temple AZ
International Classification:
A61K 38/08
C07K 7/06
US Classification:
514 16, 514 17, 530328, 530330
Abstract:
This invention generally relates to peptides useful for medical diagnosis and treatment of pathogenic disorders. More specifically, the invention relates to immunostimulatory peptides which can stimulate the production of therapeutically beneficial cytokines and, in combination with antibodies against human pathogens such as the immunodeficiency virus (HIV), inhibit replication of such pathogens. The peptides interact synergistically with pathogen-directed antibodies without producing or sustaining serious side-effects such as inflammation, and provide the potential for treatment modalities that are non-specific with respect to pathogen and cell type. Therefore, the peptides of the present invention have wide applicability with respect to medical treatment of pathogen-mediated infections, and the potential to enhance well-being.

Pro-Angiogenic Peptides

US Patent:
7838497, Nov 23, 2010
Filed:
Dec 12, 2007
Appl. No.:
11/955143
Inventors:
Laura L. Eggink - Scottsdale AZ, US
J. Kenneth Hoober - Phoenix AZ, US
Assignee:
Susavion Biosciences, Inc. - Tempe AZ
International Classification:
A61K 38/08
C07K 7/06
US Classification:
514 17, 530329, 530330
Abstract:
This present invention generally relates to peptides, compositions, treatment methods, and devices useful for the medical diagnosis and treatment of pathogenic disorders. More specifically, the invention relates to immunostimulatory peptides which can stimulate the production of therapeutically beneficial cytokines. The peptides of the invention can regulate the release of a specific pattern of cytokines that promote angiogenesis, and modulate the immune system of a subject, without inducing deleterious side effects such as inflammation. Therefore, the peptides have therapeutic importance, particularly with respect to wound healing and restoration of circulation to damaged tissues.

Immunostimulatory Compositions And Uses Thereof

US Patent:
8034773, Oct 11, 2011
Filed:
Feb 4, 2005
Appl. No.:
10/588627
Inventors:
Laura L. Eggink - Scottsdale AZ, US
Valerie Jacobs - West Lebanon NH, US
Kenneth Hoober - Phoenix AZ, US
Assignee:
Arizona Biomedical Research Commission - Phoenix AZ
International Classification:
A61K 38/10
A61K 38/16
C07K 14/00
C07K 7/00
C07K 7/08
C07K 4/00
US Classification:
514 14, 514 215, 530324, 530325, 530326, 530327, 435 691
Abstract:
The present invention provides novel immuno-stimulatory polypeptides, and methods for their use and identification.

Immunostimulatory Compositions And Uses Thereof

US Patent:
8178649, May 15, 2012
Filed:
Dec 6, 2005
Appl. No.:
11/663899
Inventors:
Laura Eggink - Scottsdale AZ, US
Valerie Jacobs - Phoenix AZ, US
Srilakshmi Bysani - Phoenix AZ, US
Kenneth J. Hoober - Phoenix AZ, US
Assignee:
Arizona Biomedical Research Commission - Phoenix AZ
International Classification:
C07K 2/00
A61K 38/00
US Classification:
530300, 514 2
Abstract:
The present invention provides novel immuno-stimulatory polypeptides, and methods for their use and identification.

Pro-Angiogenic Peptides And Uses Thereof

US Patent:
8460697, Jun 11, 2013
Filed:
Jun 25, 2010
Appl. No.:
12/823556
Inventors:
Laura L. Eggink - Scottsdale AZ, US
J. Kenneth Hoober - Phoenix AZ, US
Assignee:
Susavion Biosciences, Inc. - Tempe AZ
International Classification:
A61K 38/08
C07K 7/06
US Classification:
424443, 514 94, 514 133, 514 187, 514 218, 530329, 530330
Abstract:
This present invention is directed to peptides, compositions, and methods for modulating endogenous cytokine expression in a subject. More specifically, the invention provides peptides useful in regulating the release of a specific pattern of cytokines that promote angiogenesis and/or can be used to modulate the immune system of a subject.

Therapeutic Peptides And Uses Thereof

US Patent:
8496942, Jul 30, 2013
Filed:
Jun 25, 2010
Appl. No.:
12/823560
Inventors:
Laura L. Eggink - Scottsdale AZ, US
J. Kenneth Hoober - Phoenix AZ, US
Assignee:
Susavion Biosciences, Inc. - Tempe AZ
International Classification:
A61K 38/08
A61K 39/39
C07K 7/06
US Classification:
4242781, 514 217, 530328
Abstract:
The present invention is directed to a family of therapeutic peptides capable of modulating cytokine expression and/or stimulating the immune system of subject without producing or sustaining serious side-effects. Methods using the peptides to modulate cytokine expression in a subject, treat a disease, enhance vaccination, and stimulate a subject's immune system response are also disclosed.

Method Of Producing Purified Carotenoid Compounds

US Patent:
2004022, Nov 11, 2004
Filed:
Jun 25, 2002
Appl. No.:
10/169117
Inventors:
Laura Eggink - Scottsdale AZ, US
International Classification:
C07C013/00
US Classification:
585/023000
Abstract:
A method of producing a carotenoid in solid form includes culturing a strain of Chlorophyta algae cells in a minimal inorganic medium and separating the algae comprising a solid form of carotenoid. In one embodiment f the invention, the strain of Chlorophyta algae cells includes a strain f algae cells.

Immunostimulatory Compositions And Uses Thereof

US Patent:
2012010, May 3, 2012
Filed:
Oct 10, 2011
Appl. No.:
13/270010
Inventors:
LAURA L. EGGINK - SCOTTSDALE AZ, US
VALERIE JACOBS - WEST LEBANON NH, US
KENNETH HOOBER - PHOENIX AZ, US
Assignee:
ARIZONA BIOMEDICAL RESEARCH COMMISSION - PHOENIX AZ
International Classification:
A61K 38/16
C12N 1/21
C12N 1/13
C12N 15/63
C07K 7/06
A61K 38/10
A61K 38/08
C07K 14/00
C07K 7/08
C07H 21/04
C12N 5/10
A61P 35/00
US Classification:
514 193, 435419, 4352523, 43525233, 4352572, 4353201, 514 214, 514 215, 514 216, 530326, 530327, 536 231
Abstract:
The present invention provides novel immune-stimulatory polypeptides, and methods for their use and identification.

Possible Relatives

Danielle J Eggink  Jeff J Eggink  Nancy T Eggink  Laura L Last  Laura C Johnson  Laura J Stamps  Laura B Standish  Laura J Standley  Laura Johnston  Laura L Stanek 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.